you are here:

Tata India Pharma & Heathcare Fund - Direct Plan - Growth

  • Regular
  • Direct
Category : Sectoral/Thematic
Fund House : Tata Mutual Fund
  • NAV
    : ₹ 15.0023 -1.77%
    (as on 25th November, 2020)
Crisil Rank

Not Ranked

Rank not available for the fund
Risk-O-Meter
High

Fund has 95.51% investment in indian stocks of which 47.27% is in large cap stocks, 23.36% is in mid cap stocks, 18.85% in small cap stocks.

Suitable For : Investors who have advanced knowledge of macro trends and prefer to take selective bets for higher returns compared to other Equity funds. At the same time, these investors should also be ready for possibility of moderate to high losses in their investments even though overall market is performing better.

This Scheme
VS
  • Nifty 50
  • NA
  • NA
  • Gold
Compare with
  • Date : -
  • NAV : -
  • Nifty 50 : -
  • Date : -
  • Investment : -
  • Value on selected date : -
  • Returns Calculator
  • SIP Calculator
  • VIP (Value Avg)
Amount
  • Investment Date
  • Sell Date
  • Investment Value
    -
  • Sell Value
    -
  • Profit/Loss
    -
  • Annualised Returns
    -
  • Date : -
  • Investment : -
  • Value on selected date : -

Returns (NAV as on 25th November, 2020)

Period Invested for ₹10000 Invested on Latest Value Absolute Returns Annualised Returns Category Avg Rank within Category
1 Week 18-Nov-20 10185.30 1.85% - 0.44% 11/103
1 Month 23-Oct-20 10267.50 2.67% - 8.17% 92/103
3 Month 25-Aug-20 10605.60 6.06% - 8.70% 56/101
6 Month 22-May-20 12664.70 26.65% - 36.94% 80/101
YTD 01-Jan-20 15216.10 52.16% - 11.21% 7/99
1 Year 25-Nov-19 15063.80 50.64% 50.47% 12.13% 8/98
2 Year 22-Nov-18 16012.40 60.12% 26.38% 10.03% 6/86
3 Year 24-Nov-17 16707.50 67.07% 18.62% 4.39% 9/74
Since Inception 28-Dec-15 15002.30 50.02% 8.60% 12.19% 73/103

SIP Returns (NAV as on 25th November, 2020)

Period Invested for ₹1000 SIP Started on Investments Latest Value Absolute Returns Annualised Returns
1 Year 25-Nov-19 12000 15642.28 30.35 % 60.3 %
2 Year 22-Nov-18 24000 34957.79 45.66 % 40.72 %
3 Year 24-Nov-17 36000 54701.02 51.95 % 29.07 %
 

Tax Treatment

Portfolio (Updated on 31st Oct,2020)

Portfolio Turnover Ratio : 58.89%  |   Category average turnover ratio is 98.01%  
Fund manager updated portfolio less frequently than peers in last 1 year. (I.e. fund manager held stocks/bonds in the portfolio for longer duration than peers)
Equity Holding : 95.51% | F&O Holdings : 0.00%| Foreign Equity Holdings : 0.00%| Total : 95.51%
No of Stocks : 22 (Category Avg - 33.31) | Large Cap Investments : 47.27%| Mid Cap Investments : 23.36% | Small Cap Investments : 18.85% | Other : 6.03%

Top 10 Stocks in Portfolio

How to read this table?
Stock Invested in Sector Value(Mn) % of Total Holdings 1M Change 1Y Highest Holding 1Y Lowest Holding Quantity 1M Change in Qty
Dr. Reddys Laboratories Ltd. Pharmaceuticals 490.3 13.85% -1.61% 17.99% (Mar 2020) 13.85% (Oct 2020) 1.00 L 0.00
Sun Pharmaceutical Industries Ltd. Pharmaceuticals 321.4 9.08% -1.18% 17.08% (Jun 2020) 9.08% (Oct 2020) 6.90 L 0.00
Cipla Ltd. Pharmaceuticals 309.4 8.74% -0.70% 9.44% (Sep 2020) 0% (Nov 2019) 4.10 L 0.00
Divis Laboratories Ltd. Pharmaceuticals 290.6 8.21% -0.17% 10.88% (Apr 2020) 8.21% (Oct 2020) 92.50 k 0.00
Ipca Laboratories Ltd. Pharmaceuticals 290.1 8.20% 1.15% 8.66% (Mar 2020) 6.03% (May 2020) 1.25 L 15.93 k
Narayana Hrudayalaya Ltd. Hospital 214.3 6.05% -0.62% 6.67% (Sep 2020) 0% (Nov 2019) 6.27 L 0.00
Lupin Ltd. Pharmaceuticals 184.6 5.21% -0.87% 9.83% (Nov 2019) 5.21% (Oct 2020) 2.03 L 0.00
Laurus Labs Ltd. Pharmaceuticals 178.9 5.05% 0.27% 5.05% (Oct 2020) 0% (Nov 2019) 5.60 L 0.00
Syngene International Ltd. Pharmaceuticals 141.8 4.00% 0.71% 4% (Oct 2020) 0% (Nov 2019) 2.65 L 65.00 k
Procter & Gamble Health Ltd. Pharmaceuticals 133.7 3.78% -0.08% 6.88% (Jan 2020) 3.78% (Oct 2020) 26.00 k 0.00
- indicates change in weight in the portfolio. # indicates a new entry.
Name Type of Instrument Weight (%)
Repo Repo 4.42%
Net Receivables Net Receivables 0.06%

Risk Ratios

Ratios calculated on daily returns for last 3 years (Updated as on 29th October, 2020)

  • Standard Deviation

    High volatility
    18.24vs14.5
    Category Avg
  • Beta

    High volatility
    0.71vs0.52
    Category Avg
  • Sharpe Ratio

    Better risk adjusted returns
    0.71vs-0.04
    Category Avg
  • Treynor's Ratio

    Better risk adjusted returns
    0.18vs0.02
    Category Avg
  • Jension's Alpha

    Better risk adjusted returns
    9.55vs-1.41
    Category Avg

Alternative Funds (Category Peers)

Scheme Name
Crisil Rank
Asset Size (Cr)
1M
3M
6M
1Y
3Y
DSP Healthcare Fund - Direct Plan - Growth NA 890.49 2.19 4.61 39.47 68.69 0.00
Mirae Asset Healthcare Fund - Direct Plan - Growth NA 1036.48 0.69 4.74 29.14 62.86 0.00
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan - Growth NA 1961.72 1.59 4.33 30.84 58.33 0.00
UTI Healthcare - Direct Plan - Growth NA 586.13 1.40 4.62 28.46 55.67 15.79
ICICI Prudential Technology Fund - Direct Plan - Growth NA 832.35 1.76 19.69 72.36 54.55 25.74
Nippon India Pharma Fund - Direct Plan - Growth NA 3899.68 3.74 5.20 26.83 54.23 20.38
SBI Healthcare Opportunities Fund - Direct Plan - Growth NA 1445.32 2.59 5.86 29.35 54.01 13.76
Franklin India Technology Fund - Direct - Growth NA 388.33 4.02 18.45 51.60 49.79 24.05
IDBI Healthcare Fund - Direct Plan - Growth NA 60.33 1.01 3.03 22.23 49.37 0.00
Aditya Birla Sun Life Digital India Fund - Direct Plan - Growth NA 683.71 1.68 15.95 57.95 44.92 24.53

More Funds from Tata Mutual Fund

Out of 58 mutual fund schemes offered by this AMC, 1 is/are ranked 5 * , 10 is/are ranked 3 * , 4 is/are ranked 2 * , 4 is/are ranked 1 * , and 39 schemes are not ranked. See more about AMC

Scheme Name
Crisil Rank
Asset Size (Cr)
1M
3M
6M
1Y
3Y
Tata Liquid Fund - Direct Plan - Growth 3 15958.33 0.28 0.84 1.72 4.65 6.31
Tata Equity PE Fund - Direct Plan - Growth 3 4426.79 4.38 9.54 36.37 6.06 2.99
Tata Short Term Bond Fund - Direct Plan - Growth 3 3333.27 0.79 2.55 5.31 10.63 6.92
Tata Hybrid Equity Fund - Direct Plan - Growth 2 3170.14 6.06 8.91 31.00 4.85 4.75
Tata Arbitrage Fund - Direct Plan - Growth 5 2380.97 0.36 1.21 2.07 5.80 0.00
Tata India Tax Savings Fund - Direct Plan - Growth 3 2117.46 7.46 10.81 39.91 5.54 5.33
Tata Multicap Fund - Direct Plan - Growth NA 1682.50 4.44 8.45 33.06 7.58 0.00
Tata Large & Mid Cap Fund - Direct Plan - Appreciation 3 1666.41 8.29 8.00 38.32 8.86 7.05
Tata Treasury Advantage Fund - Direct Plan - Growth 3 1617.35 0.58 1.69 3.83 7.77 5.91
Tata Overnight Fund - Direct Plan - Growth NA 1535.87 0.24 0.76 1.53 3.58 0.00

Forum

+ See More